Dollars for Docs
How Industry Dollars Reach Your Doctors
SHARAD S MANSUKANI
Listed Specialty: Ophthalmology
411 PARK LN, MOORESTOWN, NJ, 08057-2000
DR. SHARAD MANSUKANI,
Yearly Payment Breakdown:
All Payments: At a Glance
2016
9
payments
$197,326
payment total
2
companies paid this doctor
2015
10
payments
$5,114,029
payment total
2
companies paid this doctor
2014
8
payments
$100,000
payment total
2
companies paid this doctor
2013
2
payments
$30,000
payment total
1
company paid this doctor
Payment Calendar in
This doctor received a payment on days in .
Each box below represents a single day during the disclosure period. A gray box indicates no payments. The darker the color, the more payments a doctor received that day.
Types of Payments in
Category | Payments | Payment Value |
---|---|---|
Ownership or Investment Interest |
3 | $5.03M |
Consulting |
2 | $180K |
Promotional Speaking/Other |
4 | $85,000 |
Consulting |
4 | $60,000 |
Promotional Speaking/Other |
1 | $40,000 |
Consulting |
2 | $30,000 |
Ownership or Investment Interest |
1 | $17,326 |
Drugs & Devices in
Totals listed below account for all payments from that mention this product. Beginning in 2016, the government began classifying products as drugs, devices, biologics or medical supplies. Below, you will see drugs (drugs and biologics) and devices (devices and medical supplies). If a payment record mentions more than one product, the entire value will be included in each of those products. When no products are listed, they are not included in the list below.
This physician does not have any payments relating to a specific drug or device for this year.
Product Name | Product Type | Payments† |
---|---|---|
NASCOBAL |
drug |
$60,000 |
AIS |
device |
$40,000 |
CAPTURE P |
device |
$40,000 |
† May not add up to dollar total at top of page, since a payment record may not be associated with any product or can be associated with several products. |
Payment Details in
When | How Much | Related To | What For | From | Third Party Payee |
---|---|---|---|---|---|
Oct 6, 2015 | $4,405,055 | No Listed Product | Ownership or Investment Interest | PAR PHARMACEUTICAL, INC. | |
Feb 26, 2015 | $504,221 | No Listed Product | Ownership or Investment Interest | PAR PHARMACEUTICAL, INC. | |
Dec 31, 2016 | $140,000 | No Listed Product |
Consulting
Additional details on this payment → Quarterly pay to Non-TPG Board Member |
IMMUCOR, INC. | |
Feb 26, 2015 | $119,753 | No Listed Product | Ownership or Investment Interest | PAR PHARMACEUTICAL, INC. | |
Dec 31, 2015 | $40,000 | No Listed Product |
Promotional Speaking/Other
Additional details on this payment → Quarterly pay to Non-TPA Board Member |
IMMUCOR, INC. | |
Mar 4, 2014 | $40,000 | AIS CAPTURE P | Promotional Speaking/Other | IMMUCOR, INC. | |
Dec 31, 2016 | $40,000 | No Listed Product |
Consulting
Additional details on this payment → Quarterly pay to Non-TPG Board Member |
IMMUCOR, INC. | |
Mar 17, 2016 | $17,326 | No Listed Product | Ownership or Investment Interest | PAR PHARMACEUTICAL, INC. | |
Dec 18, 2013 | $15,000 | No Listed Product | Consulting | PAR PHARMACEUTICAL, INC. | |
Jun 26, 2014 | $15,000 | NASCOBAL | Consulting | PAR PHARMACEUTICAL, INC. | |
Sep 23, 2013 | $15,000 | No Listed Product | Consulting | PAR PHARMACEUTICAL, INC. | |
Jun 26, 2015 | $15,000 | No Listed Product | Promotional Speaking/Other | PAR PHARMACEUTICAL, INC. | |
Sep 15, 2015 | $15,000 | No Listed Product | Promotional Speaking/Other | PAR PHARMACEUTICAL, INC. | |
Dec 15, 2014 | $15,000 | NASCOBAL | Consulting | PAR PHARMACEUTICAL, INC. | |
Mar 27, 2014 | $15,000 | NASCOBAL | Consulting | PAR PHARMACEUTICAL, INC. | |
Sep 22, 2014 | $15,000 | NASCOBAL | Consulting | PAR PHARMACEUTICAL, INC. | |
Mar 31, 2015 | $15,000 | No Listed Product | Promotional Speaking/Other | PAR PHARMACEUTICAL, INC. |
See this doctor’s Open Payments page →
Note: We have made some effort to normalize the data and eliminate duplicates, but data is primarily as it has been reported by the companies to the Centers for Medicare and Medicaid Services. To purchase the normalized data, please visit the ProPublica Data Store. If you spot an error, please let us know at [email protected].